Sort
15,273 grants matching “antimicrobial resistance”
Neuronal Latency and Toxoplasma
$748,925Christopher A Hunter · University Of Pennsylvania · R01 · FY2021 · AI
Triple-enriched metagenomics for robust resistome analysis
$748,594Noelle Noyes · University Of Minnesota · R01 · FY2025 · AI
Monoclonal Antibody Therapeutics for Candida auris
$748,593Arturo Casadevall · Johns Hopkins University · U19 · FY2025 · AI
Multiscale modeling of the battle over iron in invasive lung infection
$748,326Reinhard Laubenbacher · University Of Florida · R01 · FY2021 · AI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$748,142Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2021 · AI
Development of validated probes for the bacterial type III secretion system
$748,102Victoria Auerbuch Stone · University Of California Santa Cruz · R01 · FY2020 · AI
LpxH Inhibitors as Novel Therapeutics Against Multidrug-resistant Enterobacterales
$747,763Pei Zhou · Duke University · R01 · FY2025 · AI
Development of validated probes for the bacterial type III secretion system
$747,759Victoria Auerbuch Stone · University Of California Santa Cruz · R01 · FY2021 · AI
Determinants of S. aureus Colonization in Atopic Dermatitis
$747,753Donald Ym Leung · National Jewish Health · U19 · FY2017 · AI
Molecular Clonality of Uropathogenic E. Coli
$747,716Evgeni Veniaminovic Sokurenko · University Of Washington · R01 · FY2021 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Proteostasis in Plasmodium falciparum artemisinin resistance
$747,604Caroline L Ng · University Of Nebraska Medical Center · R01 · FY2025 · AI
Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium
$747,426Ankit Agarwal · Imbed Biosciences, Inc. · R44 · FY2019 · AR
VENOUS: A translational study of enterococcal bacteremia
$747,390Cesar Augusto Arias · Methodist Hospital Research Institute · R01 · FY2024 · AI
IgM in the regulation of TB immunity
$747,370John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Targeted antibiotic therapy for Shigella among children in low-resource settings
$746,813Elizabeth Tacket Rogawski McQuade · Emory University · R01 · FY2024 · AI
Developing therapeutics to treat chronic infections
$746,404Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2014 · AI
Proteostasis in Plasmodium falciparum artemisinin resistance
$746,268Caroline L Ng · University Of Nebraska Medical Center · R01 · FY2024 · AI
A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans
$746,230Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2019 · AT
HLS- Cyclic CAR peptide: a targeted therapy for pulmonary hypertension
$746,137Paul B Yu · Vascular Biosciences · R42 · FY2019 · HL
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$746,060Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2019 · AI
The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)
$746,005Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2023 · AI
Longitudinal Study of the Vaginal Microbiome Prior To Incident STI
$745,886Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2015 · AI